Proteostasis Therapeutics, Inc.
(NASDAQ : PTI)

( )
PTI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.45%201.801.2%$542.05m
GILDGilead Sciences, Inc.
-1.21%73.270.9%$465.10m
BIIBBiogen Inc.
-2.95%320.411.3%$380.15m
CELGCelgene Corporation
-0.65%82.411.2%$337.48m
ILMNIllumina, Inc.
-2.60%313.103.5%$332.96m
REGNRegeneron Pharmaceuticals, Inc.
-1.36%389.832.6%$235.91m
VRTXVertex Pharmaceuticals Incorporated
-1.79%175.691.9%$230.46m
ALXNAlexion Pharmaceuticals, Inc.
-0.53%125.892.0%$220.48m
SRPTSarepta Therapeutics, Inc.
-3.30%134.2216.4%$169.84m
AAgilent Technologies, Inc.
-1.95%64.471.5%$159.28m
BMRNBioMarin Pharmaceutical Inc.
-0.58%103.224.4%$142.60m
LGNDLigand Pharmaceuticals Incorporated
-4.84%187.5223.3%$115.84m
EXASExact Sciences Corporation
-2.88%61.6425.3%$102.69m
NKTRNektar Therapeutics
-2.76%48.195.6%$101.86m
NBIXNeurocrine Biosciences, Inc.
-2.24%112.015.1%$98.21m

Company Profile

Proteostasis Therapeutics, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat cystic fibrosis, protein conformational and neurodegenerative diseases. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.